Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streamlining the Abstract Selection Process for the American Society of Breast Surgeons' Annual Meeting by Utilizing Large Language Models.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age.

Annals of surgical oncology·2026
Same author

Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age.

Annals of surgical oncology·2026
Same author

Surgical Perspective on the Updated American College of Radiology Supplemental Screening Guidelines for Breast Density.

Annals of surgical oncology·2026
Same author

Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.

American journal of surgery·2026
Same author

Reply to: "Breast-Conserving Surgery After Neoadjuvant Therapy in Multiple Ipsilateral Breast Cancer: Points to Consider," by Sanli, Deniz et al.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Apr 29, 2026

Intraductal Delivery to the Rabbit Mammary Gland
06:30

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

9.0K

Breast conserving therapy for DCIS--does size matter?

Olga Kantor1, David J Winchester

  • 1University of Chicago, Pritzker School of Medicine, Chicago, Illinois.

Journal of Surgical Oncology
|May 28, 2014
PubMed
Summary
This summary is machine-generated.

Screening mammography has increased ductal carcinoma in situ diagnoses. Tumor size is crucial for selecting patients for breast conserving surgery and predicting local recurrence risk.

Keywords:
breast-conserving surgerylocal recurrencemammography

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
13:43

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

4.6K

Related Experiment Videos

Last Updated: Apr 29, 2026

Intraductal Delivery to the Rabbit Mammary Gland
06:30

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

9.0K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
13:43

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

4.6K

Area of Science:

  • Oncology
  • Radiology
  • Surgical Oncology

Background:

  • Screening mammography has led to a significant rise in ductal carcinoma in situ (DCIS) diagnoses.
  • Breast conserving therapy is a viable option for most DCIS patients, contingent on clinical and pathological factors.

Purpose of the Study:

  • To highlight the importance of tumor size in patient selection for breast conserving surgery.
  • To underscore the role of tumor size in predicting the risk of local recurrence after DCIS treatment.

Main Methods:

  • This study reviews current literature and clinical guidelines regarding DCIS management.
  • Analysis of patient and pathological variables influencing treatment decisions.

Main Results:

  • Tumor size is a critical determinant in choosing between breast conserving surgery and other treatment modalities.
  • Accurate tumor size assessment aids in stratifying patients based on their risk of local recurrence.

Conclusions:

  • Tumor size is a key factor in optimizing patient selection for breast conserving surgery in DCIS.
  • Incorporating tumor size into risk assessment models can improve prediction of local recurrence, guiding personalized treatment strategies.